Insider Trading disclosures for Puma Biotechnology Inc

The latest disclosure was made by Alan H. Auerbach in Puma Biotechnology Inc where a trade of 198,399 Common Stock done was reported to US exchanges on Feb. 7, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	198,399	7,228,073 (18%)	0%		0	Common Stock
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	274,622	274,622	-		-	Stock Option (Right to Buy)
Douglas M. Hunt	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	48,117	172,711 (0%)	0%		0	Common Stock
Douglas M. Hunt	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	66,604	66,604	-		-	Stock Option (Right to Buy)
Maximo F. Nougues	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	85,067	85,067	-		-	Stock Option (Right to Buy)
Maximo F. Nougues	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	61,456	213,751 (0%)	0%		0	Common Stock
Jeffrey Jerome Ludwig	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	66,221	66,221	-		-	Stock Option (Right to Buy)
Jeffrey Jerome Ludwig	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2025	47,841	156,792 (0%)	0%		0	Common Stock
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 3.15 per share.	02 Jan 2025	33,841	7,029,674 (17%)	0%	3.2	106,657	Common Stock
Douglas M. Hunt	See Remarks	Sale of securities on an exchange or to another person at price $ 3.15 per share.	02 Jan 2025	8,633	124,594 (0%)	0%	3.2	27,209	Common Stock
Maximo F. Nougues	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.15 per share.	02 Jan 2025	10,227	152,295 (0%)	0%	3.2	32,232	Common Stock
Jeffrey Jerome Ludwig	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 3.15 per share.	02 Jan 2025	9,437	108,951 (0%)	0%	3.2	29,743	Common Stock
Michael P Miller	Director	Sale of securities on an exchange or to another person at price $ 3.49 per share.	12 Aug 2024	23,358	47,000 (0%)	0%	3.5	81,466	Common Stock
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 3.70 per share.	17 Jul 2024	21,920	7,063,515 (17%)	0%	3.7	81,128	Common Stock
Douglas M. Hunt	See Remarks	Sale of securities on an exchange or to another person at price $ 3.70 per share.	17 Jul 2024	3,637	133,227 (0%)	0%	3.7	13,461	Common Stock
Maximo F. Nougues	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.70 per share.	17 Jul 2024	4,156	162,522 (0%)	0%	3.7	15,382	Common Stock
Jeffrey Jerome Ludwig	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 3.70 per share.	17 Jul 2024	2,598	118,388 (0%)	0%	3.7	9,615	Common Stock
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 3.27 per share.	02 Jul 2024	18,885	7,085,435 (18%)	0%	3.3	61,726	Common Stock
Douglas M. Hunt	See Remarks	Sale of securities on an exchange or to another person at price $ 3.27 per share.	02 Jul 2024	4,349	136,864 (0%)	0%	3.3	14,215	Common Stock
Maximo F. Nougues	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.27 per share.	02 Jul 2024	5,295	166,678 (0%)	0%	3.3	17,307	Common Stock
Jeffrey Jerome Ludwig	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 3.27 per share.	02 Jul 2024	6,051	120,986 (0%)	0%	3.3	19,778	Common Stock
Michael P Miller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	95,358 (0%)	0%		0	Common Stock
Jay M. Moyes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	48,322 (0%)	0%		0	Common Stock
Troy E. Wilson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	27,350 (0%)	0%		0	Common Stock
Adrian Senderowicz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	27,000 (0%)	0%		0	Common Stock
Allison Dorval	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	60,000 (0%)	0%		0	Common Stock
Brian M. Stuglik	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	76,058 (0%)	0%		0	Common Stock
Alessandra Cesano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	27,000	54,000 (0%)	0%		0	Common Stock
Jay M. Moyes	Director	Sale of securities on an exchange or to another person at price $ 3.34 per share.	13 Jun 2024	22,000	21,322 (0%)	0%	3.3	73,467	Common Stock
Troy E. Wilson	Director	Sale of securities on an exchange or to another person at price $ 3.33 per share.	13 Jun 2024	27,000	350 (0%)	0%	3.3	89,902	Common Stock
Adrian Senderowicz	Director	Sale of securities on an exchange or to another person at price $ 3.33 per share.	13 Jun 2024	27,000	0 (0%)	0%	3.3	89,818	Common Stock
Allison Dorval	Director	Sale of securities on an exchange or to another person at price $ 3.37 per share.	13 Jun 2024	11,000	33,000 (0%)	0%	3.4	37,096	Common Stock
Brian M. Stuglik	Director	Sale of securities on an exchange or to another person at price $ 3.39 per share.	13 Jun 2024	9,900	49,058 (0%)	0%	3.4	33,528	Common Stock
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2024	9,047	9,047	-		-	Stock Option (Right to Buy)
Alan H. Auerbach	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2024	6,577	7,104,320 (18%)	0%		0	Common Stock
Hunt Douglas M.	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	37,894	141,213 (0%)	0%		0	Common Stock
Wong F. Alvin	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	43,307	141,241 (0%)	0%		0	Common Stock
F. Nougues Maximo	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	59,946	59,946	-		-	Stock Option (Right to Buy)
Auerbach Alan H.	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	160,796	7,097,743 (18%)	0%		0	Common Stock
H. Auerbach Alan	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	222,573	222,573	-		-	Stock Option (Right to Buy)
Ludwig Jeffrey Jerome	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	27,067	127,037 (0%)	0%		0	Common Stock
Douglas M. Hunt	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	52,452	52,452	-		-	Stock Option (Right to Buy)
Jerome Ludwig Jeffrey	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	37,466	37,466	-		-	Stock Option (Right to Buy)
F. Maximo Nougues	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	43,307	171,973 (0%)	0%		0	Common Stock
F. Wong Alvin	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	59,946	59,946	-		-	Stock Option (Right to Buy)
Alan Auerbach H.	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.49 per share.	03 Jan 2024	41,396	6,936,947 (17%)	0%	4.5	185,698	Common Stock
Nougues Maximo F.	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 4.49 per share.	03 Jan 2024	15,682	128,666 (0%)	0%	4.5	70,348	Common Stock
Jeffrey Ludwig Jerome	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 4.49 per share.	03 Jan 2024	12,956	99,970 (0%)	0%	4.5	58,119	Common Stock
Alvin F. Wong	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 4.49 per share.	03 Jan 2024	7,733	98,214 (0%)	0%	4.5	34,689	Common Stock
Douglas Hunt M.	See Remarks	Sale of securities on an exchange or to another person at price $ 4.49 per share.	03 Jan 2024	8,358	103,319 (0%)	0%	4.5	37,493	Common Stock

Showing 1 to 50 of 436 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

44.88% Fall from 52W High

Insider Trading disclosures for Puma Biotechnology Inc

The latest disclosure was made by Alan H. Auerbach in Puma Biotechnology Inc where a trade of 198,399 Common Stock done was reported to US exchanges on Feb. 7, 2025.

Screeners based on Insider Trading and SAST parameters